Merck & Company, Inc. News Headlines

MRK 
$57.97
*  
0.18
0.31%
Get MRK Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Merck - Little Appeal Despite Recently Announced Cost Cuts
10/14/2013 2:18:00 PM - Seeking Alpha

Is Merck Still A Good Buy?
10/14/2013 1:54:00 PM - Seeking Alpha

MT Insider: Barclays Cuts Merck to Equal Weight With $50 Price Target; Sees Top-Line Pressure on Core Businesses
10/14/2013 11:41:08 AM - MT Newswires

Update on VIVUS' Qsymia - Analyst Blog
10/14/2013 11:40:01 AM - Zacks.com

Can Johnson & Johnson (JNJ) Keep the Earnings Streak Alive? - Analyst Blog
10/14/2013 8:58:37 AM - Zacks.com

Market Tops Start With Champagne And End In Tears; Washington May Trigger This One
10/13/2013 2:03:00 AM - Seeking Alpha

Johnson & Johnson Earnings Preview: Pharmaceutical Business Will Get Bigger
10/10/2013 2:56:58 PM - Trefis

Fed Minutes, Yellen Appointment Help Halt Selling Pressure
10/9/2013 4:19:50 PM - Schaeffer's Investment Research

8 Drug And Device 9% To 21% September Upsides Paced Healthcare Dogs
10/9/2013 3:00:00 PM - Seeking Alpha

Veeva Systems: Cloud Bases Services For The Life Science Industry.
10/9/2013 2:45:00 PM - Seeking Alpha

Bristol-Myers Squibb Will Prove To Be A Solid Investment
10/9/2013 2:04:00 PM - Seeking Alpha

Investing 101: Like the Product, Buy the Stock
10/7/2013 8:21:00 AM - Fox Business

Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
10/6/2013 8:57:00 PM - Seeking Alpha

Is Skin Cancer On The Way To Becoming A Curable Disease?
10/6/2013 7:16:00 AM - Seeking Alpha

Eli Lily to Cut Costs, Shares Down - Analyst Blog
10/4/2013 12:50:01 PM - Zacks.com

Update on Merck's Restructuring Efforts - Analyst Blog
10/3/2013 4:48:24 PM - Zacks.com

Merck Streamlines Operations, Sacks 8,500 More Employees
10/3/2013 11:35:00 AM - Seeking Alpha

Eli Lilly Warns of '14 Revenue Headwinds
10/3/2013 9:30:00 AM - Fox Business

Update on AstraZeneca's Onglyza - Analyst Blog
10/2/2013 10:46:01 AM - Zacks.com

Update on Tetraphase's Pipeline - Analyst Blog
10/2/2013 10:09:01 AM - Zacks.com

Stock Downgrades: Wall Street, Why Did U-Turn on Tesla?
10/2/2013 9:21:00 AM - Minyanville

First Government Shutdown in 17 Years Sends Stocks Rocketing Higher
10/1/2013 4:50:00 PM - Minyanville

Top-line Data on Astellas' Isavuconazole - Analyst Blog
10/1/2013 4:30:01 PM - Zacks.com

Stocks Notch Daily Gains as Shutdown Becomes a Reality
10/1/2013 4:20:54 PM - Schaeffer's Investment Research

Healthcare Stocks Rising; Merck to Lay Off 8,500 Workers, Reports Positive Early Results for Lung Cancer Drug
10/1/2013 1:58:18 PM - MT Newswires